A Food and Drug advisory panel noted certain side effects to Vivus Inc.'s (Nasdaq: VVUS) obesity treatment Qnexa but said that use of the drug does result in significant loss of weight. The stock price climbed $1.79 to close at $12.44.
Significant Weight Loss With Vivus' Qnexa
July 13, 2010 at 17:11 PM EDT
